ProfileGDS5678 / 1454546_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 46% 45% 45% 43% 44% 44% 49% 44% 44% 44% 45% 44% 53% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1143446
GSM967853U87-EV human glioblastoma xenograft - Control 23.0481245
GSM967854U87-EV human glioblastoma xenograft - Control 33.0493545
GSM967855U87-EV human glioblastoma xenograft - Control 42.9454143
GSM967856U87-EV human glioblastoma xenograft - Control 52.960144
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1252144
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2413449
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0133144
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9927244
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0169544
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0355145
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9982944
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3223953
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.046545